HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[No-reflow phenomenon occurring during elective angioplasty performed due to in-stent restenosis -- a case report].

Abstract
The no-reflow phenomenon is an impairment of microcirculation after successful percutaneous coronary interventions (PCI). The no-reflow phenomenon is usually observed during acute myocardial infarction. This case-report describes no-reflow phenomenon in a patient undergoing elective PCI in the right coronary artery, occluded due to restenosis in implanted stent. After deflation of balloon during angioplasty in restenosed stent, no-reflow phenomenon occurred, followed by asystolia. The patient was successfully resuscitated. During resuscitation procedures, abciximab was administered what improved myocardial perfusion. This case demonstrates that no-reflow phenomenon can be a serious problem during elective PCI, leading even to a cardiac arrest. It shows also the necessity for administration of drugs improving tissue perfusion when no-reflow phenomenon occurs.
AuthorsSławomir Dobrzycki, Konrad Nowak, Marcin Kozuch, Hanna Bachórzewska-Gajewska, Bogusław Poniatowski, Jerzy Zuk
JournalKardiologia polska (Kardiol Pol) Vol. 64 Issue 4 Pg. 437-40 (Apr 2006) ISSN: 0022-9032 [Print] Poland
Vernacular TitleZespół upośledzonej perfuzji tkankowej u chorego poddanego planowej interwencji wieńcowej w obrebie zwezenia we wcześniej implantowanym stencie.
PMID16699996 (Publication Type: Case Reports, English Abstract, Journal Article)
Topics
  • Angioplasty, Balloon, Coronary (adverse effects)
  • Catheterization (adverse effects)
  • Coronary Angiography
  • Coronary Circulation
  • Coronary Restenosis (physiopathology, therapy)
  • Heart Arrest (etiology)
  • Humans
  • Male
  • Middle Aged
  • Resuscitation
  • Stents (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: